I 
113TH CONGRESS 
2D SESSION 
H. R. 4384 
To provide for the establishment of a fund to provide for an expanded 
and sustained national investment in biomedical research. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 3, 2014 
Ms. ESHOO (for herself, Ms. LOFGREN, Ms. MATSUI, Mr. CARSON of Indiana, 
Mr. HUFFMAN, Mr. VARGAS, and Mr. PETERS of California) introduced 
the following bill; which was referred to the Committee on Energy and 
Commerce, and in addition to the Committees on the Budget, Armed 
Services, and Veterans’ Affairs, for a period to be subsequently deter-
mined by the Speaker, in each case for consideration of such provisions 
as fall within the jurisdiction of the committee concerned 
A BILL 
To provide for the establishment of a fund to provide for 
an expanded and sustained national investment in bio-
medical research. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘America Helping En-
courage Advancements in Lifesaving Science’’ or the 
‘‘America HEALS Act’’. 
VerDate Mar 15 2010 
01:02 Apr 05, 2014
Jkt 039200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H4384.IH
H4384
tjames on DSK6SPTVN1PROD with BILLS
SEC. 2. BIOMEDICAL RESEARCH FUND. 
(a) PURPOSE.—It is the purpose of this section to 
establish a Biomedical Research Fund (referred to in this 
section as the ‘‘Fund’’), to be administered by the Sec-
retary of the Treasury, to provide for an expanded and 
sustained national investment in biomedical research 
through the programs and agencies described in sub-
section (b)(2). 
(b) USE OF FUND.— 
(1) IN
GENERAL.—For each fiscal year, 
amounts shall be transferred from the Fund to the 
accounts related to the programs and agencies de-
scribed in paragraph (2) to ensure that funding for 
such programs and agencies for such fiscal year does 
not fall below 105 percent of the level of funding 
provided for the fiscal year immediately preceding 
the fiscal year for which the determination is being 
made and an additional amount to account for any 
increases in the Gross Domestic Product for the 
year involved. 
(2) AGENCIES.—The programs and agencies de-
scribed in this paragraph are the following: 
(A) The National Institutes of Health. 
(B) The Centers for Disease Control and 
Prevention. 
VerDate Mar 15 2010 
01:02 Apr 05, 2014
Jkt 039200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H4384.IH
H4384
tjames on DSK6SPTVN1PROD with BILLS
(C) The Department of Defense health 
program. 
(D) The medical and prosthetics research 
program of the Department of Veterans Affairs. 
(c) MINIMUM
CONTINUED
FUNDING
REQUIRE-
MENT.—Amounts appropriated for each of the programs 
and agencies described in subsection (b)(2) for a fiscal 
year shall not be less than the amounts appropriated for 
such programs and agencies for fiscal year 2014. 
(d) FUNDING.—There are hereby authorized to be 
appropriated, and appropriated, to the Fund, out of any 
monies in the Treasury not otherwise appropriated, such 
sums as may be necessary in each fiscal year to enable 
the transfers to be made in accordance with subsection 
(b)(1). 
(e) TRANSFER AUTHORITY.—The Committee on Ap-
propriations of the Senate and the Committee on Appro-
priations of the House of Representatives may provide for 
the transfer of funds in the Fund to eligible programs and 
agencies under this section, subject to subsection (b). 
(f) EXEMPTION OF CERTAIN PAYMENTS FROM SE-
QUESTRATION.— 
(1) IN GENERAL.—Section 255(g)(1)(A) of the 
Balanced Budget and Emergency Deficit Control 
Act (2 U.S.C. 905(g)(1)(A)) is amended by inserting 
VerDate Mar 15 2010 
01:02 Apr 05, 2014
Jkt 039200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H4384.IH
H4384
tjames on DSK6SPTVN1PROD with BILLS